Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Halse

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Clinical Endocrinology|February 1, 1995
Autonomous hyperparathyroidism in X-linked hypophosphataemiaJ Knudtzon, J Halse, E Monn, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1990
A randomized study of SMS 201-995 versus bromocriptine treatment in acromegaly: clinical and biochemical effectsJ Halse, A G Harris, A Kvistborg, et al.
International Journal of Obesity (2005)|October 13, 2006
The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obeseC Syvertsen, J Halse, H O Høivik, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetesM H Tan, D Johns, J Strand, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Consensus development statement on osteoporosisO H Sørensen, S P Nielsen, P Charles, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1990
[Are prosecuted parents allowed the benefit of the doubt in cases of child abuse?]T Aakhus, F Brosstad, J Halse, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 17, 2016
Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 studyR Rizzoli, C-L Benhamou, J Halse, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Clinical Endocrinology|February 1, 1995
Autonomous hyperparathyroidism in X-linked hypophosphataemiaJ Knudtzon, J Halse, E Monn, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1990
A randomized study of SMS 201-995 versus bromocriptine treatment in acromegaly: clinical and biochemical effectsJ Halse, A G Harris, A Kvistborg, et al.
International Journal of Obesity (2005)|October 13, 2006
The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obeseC Syvertsen, J Halse, H O Høivik, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetesM H Tan, D Johns, J Strand, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Consensus development statement on osteoporosisO H Sørensen, S P Nielsen, P Charles, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1990
[Are prosecuted parents allowed the benefit of the doubt in cases of child abuse?]T Aakhus, F Brosstad, J Halse, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 17, 2016
Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 studyR Rizzoli, C-L Benhamou, J Halse, et al.
Pageof 8